Dicerna Pharmaceuticals Inc (DRNA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that offers therapies. The company discovers and develops treatments for rare inherited diseases including liver and for cancers that are genetically defined. It offers RNAi technology platform GalXCTM, which is a advances the development of next-generation RNAi-based therapies that is designed to silence disease-driving genes in the liver. Dicernas GalXC-based therapies are processed by the Dicer enzyme, which is the natural initiation point for RNAi within the human cell. The company develops therapies to treat diseases linking the liver such as rare diseases, viral infectious diseases, chronic liver diseases, and cardiovascular diseases. Dicerna is headquartered in Cambridge, Massachusetts, the US.

Dicerna Pharmaceuticals Inc (DRNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Dicerna Pharma Raises US$60 Million In Series C Financing 11
Private Equity 13
Dicerna Pharma Raises USD70 Million in Convertible Preferred Stock Financing 13
Partnerships 15
Boehringer Ingelheim International Enters into Research Agreement with Dicerna Pharma 15
Licensing Agreements 16
Dicerna Pharma Enters into Licensing Agreement with Tekmira Pharma 16
Dicerna Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe & Hamilton RNAi Patents 17
Equity Offering 18
Dicerna Pharma Plans to Raise USD250 Million in Public Offering of Securities 18
Dicerna Pharma to Raise Funds through Public Offering of Shares 19
Dicerna Pharma Raises USD43.2 Million in Public Offering of Shares 20
Dicerna Pharma Raises USD48.8 Million in Public Offering of Shares 22
Dicerna Pharma Completes IPO For US$103.5 Million 23
Dicerna Pharmaceuticals Inc - Key Competitors 25
Dicerna Pharmaceuticals Inc - Key Employees 26
Dicerna Pharmaceuticals Inc - Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Financial Announcements 28
May 14, 2018: Dicerna Reports First Quarter 2018 Financial and Operating Results and Provides Corporate Update 28
Mar 08, 2018: Dicerna Reports Fourth Quarter and Year End 2017 Financial and Operating Results and Provides Corporate Update 30
Nov 02, 2017: Dicerna Reports Third Quarter 2017 Financial and Operating Results and Provides Corporate Update 33
Aug 10, 2017: Dicerna Reports Second Quarter 2017 Financial and Operating Results and Provides Corporate Update 35
May 08, 2017: Dicerna Reports First Quarter 2017 Financial and Operational Results and Provides Corporate Update 37
Mar 30, 2017: Dicerna Reports Fourth Quarter and Full Year 2016 Financial and Operational Results 39
Corporate Communications 41
Jun 15, 2017: Dicerna Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 41
Jun 08, 2017: Dicerna Announces Appointment of Ralf Rosskamp, M.D., as Chief Medical Officer 42
Feb 02, 2017: Dicerna Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 43
Legal and Regulatory 44
Apr 20, 2018: Dicerna Pharmaceuticals Announces Settlement of All Litigation with Alnylam 44
Apr 20, 2018: Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade Secret Misappropriation and Other Pending Litigation 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List Of Tables

List of Tables
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dicerna Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dicerna Pharma Raises US$60 Million In Series C Financing 11
Dicerna Pharma Raises USD70 Million in Convertible Preferred Stock Financing 13
Boehringer Ingelheim International Enters into Research Agreement with Dicerna Pharma 15
Dicerna Pharma Enters into Licensing Agreement with Tekmira Pharma 16
Dicerna Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe & Hamilton RNAi Patents 17
Dicerna Pharma Plans to Raise USD250 Million in Public Offering of Securities 18
Dicerna Pharma to Raise Funds through Public Offering of Shares 19
Dicerna Pharma Raises USD43.2 Million in Public Offering of Shares 20
Dicerna Pharma Raises USD48.8 Million in Public Offering of Shares 22
Dicerna Pharma Completes IPO For US$103.5 Million 23
Dicerna Pharmaceuticals Inc, Key Competitors 25
Dicerna Pharmaceuticals Inc, Key Employees 26

List Of Figures

List of Figures
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dicerna Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Dicerna Pharmaceuticals, Inc. - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Dicerna Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Dicerna Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

Dicerna Pharmaceuticals Inc (DRNA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that offers therapies. The company discovers and develops treatments for rare inherited diseases including liver and for cancers that are genetically defined.

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available